Healthcare | April 27, 2026
IKS Health to acquire TruBridge in $26.25-a-share deal to expand rural healthcare reach
The deal signals a clear push to expand access to care in underserved regions
The deal signals a clear push to expand access to care in underserved regions
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Growth was broad-based across segments
Subscribe To Our Newsletter & Stay Updated
